Multiplex Real-time PCR Kits Detects Over 450 β Lactamase Gene Targets.
Streck is introducing a new line of antibiotic resistance monitoring and detection (ARM-D) kits. The Streck ARM-D® Kit, ampC (RUO) and Streck ARM-D® Kit, β-Lactamase (RUO) are multiplex real-time PCR kits that can quickly detect more than 450 β lactamase gene targets.
The kits are designed to detect the carbapenem-resistant Enterobacteriaceae (CRE) genes currently on the CDC’s Urgent Threat list as well as additional emerging threats. Current phenotypic methods can mischaracterize or fail to detect genetic mechanisms of antibiotic resistance. The Streck ARM-D Kits are a genotypic detection method that can be used to identify the most prevalent types of β-lactamase-based antibiotic resistance.
Streck developed the ARM-D Kits to provide laboratories with a comprehensive, cost-effective molecular method to detect the most clinically-important β-lactamases known to cause therapeutic failure. These kits can be used to complement standard susceptibility tests and to improve surveillance and epidemiologic tracking, which will translate into better infection control and increased effectiveness of antibiotic stewardship programs.
Streck ARM-D Kits are For Research Use Only. Not for use in diagnostic procedures. These products have not been cleared by the U.S. Food and Drug Administration for In Vitro Diagnostic use.
Date Published: November 1, 2016
Source article link: Streck » company contact details